Crossmark

Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer

Crossref DOI link: https://doi.org/10.1038/s41391-025-01055-7

Published Online: 2025-11-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gagnon, Autumn

Zhong, Caiwei

Xie, Wanling

Morlock, Lynne

Freeman, Dory

Trowbridge, Rachel

Kilbridge, Kerry L.

McGregor, Bradley A. https://orcid.org/0000-0002-8298-0289
Taplin, Mary-Ellen

Choudhury, Atish D. https://orcid.org/0000-0001-9344-6631
License Information

Text and Data Mining valid from 2025-11-18

Version of Record valid from 2025-11-18
More Information

Article History

First Online: 18 November 2025

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below